RECORD // Company
Lisata Therapeutics, Inc.
Formerly: Caladrius Biosciences, Inc.; CALADRIUS BIOSCIENCES, INC.; NeoStem, Inc.; PHASE III MEDICAL INC/DE; CORNICHE GROUP INC /DE
Built 2026-11-21T19:10:13Z from public sources · JSON · Open the company profile
ASK THE RECORDS
Ask
COMPANY
Records for this company (1 joined by official identifier)
Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.
SEC EDGAR (1)
- LISATA THERAPEUTICS, INC. · the SEC registrant record of this company
Matched by name only, not merged (3)
These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).
- Lisata Therapeutics, Inc. · Ctgov · same registered legal name as 'LISATA THERAPEUTICS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
- LISATA THERAPEUTICS INC. · East licences · same registered legal name as 'LISATA THERAPEUTICS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
- LISATA THERAPEUTICS, INC. · Ny corps · same registered legal name as 'LISATA THERAPEUTICS, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
3 VALUES · 10-Q · EACH LINKS TO ITS FILING
Latest quarter
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-13 · accession 0000320017-26-000044
| Item | Value | Period | Form | Filed | Accession | Report | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | 3 months ended 2026-09-30 | 10-Q | 2026-11-13 | 0000320017-26-000044 | 2026-11-21 19:10 UTC | Report an error |
| Net income (loss) | $-6,787,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-13 | 0000320017-26-000044 | 2026-11-21 19:10 UTC | Report an error |
| Cash and cash equivalents | $282,717,000 | at 2026-09-30 | 10-Q | 2026-11-13 | 0000320017-26-000044 | 2026-11-21 19:10 UTC | Report an error |
Negative as reported in the filing.
Not in this report's XBRL: Interest expense.
Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.
IDS
Identifiers
- SEC CIK
- 0000320017
- Ticker
- LSTA
- EIN
- 222343568
- CUSIP
- 128058302
- Record ID
- sx:sec:0000320017
OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA
Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
31 FACTS · EACH LINKS TO ITS FILING
Facts
EVERY DATED RECORD, NEWEST FIRST
Timeline
- 2026-11-19 Filing S-3/A filed
- 2026-11-19 Filing 8-K/A filed: Item 9.01 exhibits
- 2026-11-19 Filing 8-K filed: Item 3.03 rights of holders modified; Item 5.03 charter or bylaw amendment; Item 8.01 other event; Item 9.01 exhibits
- 2026-11-13 Filing 10-Q filed
- 2026-11-12 Filing S-3 filed
- 2026-11-12 Filing S-8 filed
- 2026-11-12 Filing 8-K/A filed: Item 9.01 exhibits
- 2026-11-09 Filing DEFA14A filed
- 2026-11-09 Filing 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 8.01 other event; Item 9.01 exhibits
- 2026-10-19 Filing ARS filed
- 2026-10-19 Filing DEF 14A filed
- 2026-10-14 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-10-07 Filing PRE 14A filed
- 2026-10-02 Filing D filed
- 2026-09-17 Filing 8-K filed: Item 1.01 material agreement; Item 2.01 acquisition or disposition; Item 3.02 unregistered equity sale; Item 5.02 officer or director change; Item 5.03 charter or bylaw amendment; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-08-06 Filing 10-Q filed
- 2026-08-04 Filing 8-K filed: Item 2.05 exit or disposal costs; Item 5.02 officer or director change; Item 8.01 other event; Item 9.01 exhibits
- 2026-07-28 Filing SC TO-T/A filed
- 2026-07-24 Filing 8-K filed: Item 1.02 agreement terminated; Item 8.01 other event
- 2026-07-21 Filing SC 14D9/A filed
- 2026-07-17 Filing 8-K filed: Item 1.01 material agreement; Item 9.01 exhibits
- 2026-07-17 Filing SC 14D9/A filed
- 2026-07-17 Filing SC TO-T/A filed
- 2026-07-13 Filing SC 14D9/A filed
- 2026-07-10 Filing SC TO-T/A filed (SCHEDULE TO-T/A)
WHAT IS NOT HERE
Gaps
- Court records: not covered yet (expected 11-19).
- No H-1B LCA filed under EIN 222343568 in FY2026 Q3
- H-1B LCAs only (H-1B1 and E-3 excluded); one fiscal quarter (FY2026 Q3) only, earlier quarters not loaded
- No Form 5500 plan filed under sponsor EIN 222343568 for plan year 2025
- Plan year 2025 only (EFAST2 'Latest' file); earlier years not loaded
- No Form 990 found for EIN 222343568
- USAspending: no recipient whose SAM legal name and address match this SEC filer
SOURCES AND LICENSE
Sources
- SEC EDGAR: checked · 2026-11-21T19:10:14Z
- DOL OFLC LCA Disclosure Data: checked, nothing found · 2026-11-21T19:10:15Z
- DOL EBSA Form 5500 public datasets: checked, nothing found · 2026-11-21T19:10:15Z
- Propublica 990: checked, nothing found · 2026-11-21T19:10:15Z
- SEC 13F holdings: checked · 2026-11-21T19:10:15Z
- USAspending: checked, nothing found · 2026-11-21T19:10:19Z
CC BY 4.0 -- credit Seraphix Systems.
API
Use this record
Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.